# A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee

> **NCT04129944** · PHASE2 · COMPLETED · sponsor: **Unity Biotechnology, Inc.** · enrollment: 183 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** UBX0101
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04129944
- **Lead sponsor:** Unity Biotechnology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-30
- **Primary completion:** 2020-05-20
- **Final completion:** 2020-08-07
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2021-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04129944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04129944, "A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04129944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*